Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 348 results for "pfizer"

Should JNJ, AbbVie and Amgen Feel Threatened by Remicade Biosimilar?
Bidness Etc

Should JNJ, AbbVie and Amgen Feel Threatened by Remicade Biosi...

On Tuesday, a medical advisory panel to the Food and Drug Administration (FDA) recommended Pfizer Inc. ( NYSE:PFE ) and Celltrion Inc.'s Remicade biosimilar for approval. With the panel's recommendation, the drug, named Remsima, now has better ... Bidness Etc, 7 hours ago

280 images for pfizer

Watch List News, 3 hours ago
American Banking News - Earnings, 18 hours ago
One News Page United Kingdom, 1 hour ago
Palestine Telegraph, 9 hours ago
Pharma Letter, 2 days ago
Motley Fool, 2 days ago
Chain Drug Review, 2 days ago
West Australian, 3 days ago
IOL, 2 days ago
4 Traders, 3 days ago
Investor's Business Daily

DuPont Becomes #7 Most Shorted Dow Stock, Replacing Pfizer

 Forbes.com10 hours ago The New #4 Most Shorted Dow Component: Pfizer  Forbes.com10 hours ago Pfizer To Reorganize After Allergan Buyout, With Saunders President  Minyanville3 days ago

SC 13G/A - PFIZER INC (0000078003) (Subject)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] SEC Accession No. 0000932471-16-012084 Filing Date 2016-02-11 Accepted 2016-02-11 09:51:35 Documents 1 Filing Date Changed 2016-02-11 Document Format Files Seq ...
 SEC9 hours ago

Pfizer Inc Stock: Why Merrill Lynch Sees Up To 51% Upside

Pfizer Inc. ( NYSE:PFE ) shot up 2% in Tuesday's trade on a particularly bullish research note by Merrill Lynch. The NYSE ARCA Pharmaceutical Index (DRG) remained nearly flat during the time. Analyst Colin Bristow recommends an immediate Buy on the ...
 Bidness Etc10 hours ago Why Merrill Lynch Sees Big Upside in Pfizer (and Even More With Allergan)  24/7 Wall St2 days ago

Pfizer Consumer Healthcare Partners with Galvanize to Launch Health and Wellness Innovation Program in San Francisco

_ The first cohort of companies will be jointly selected by Galvanize and Pfizer Consumer Healthcare for a six-month program beginning on March 7, 2016 "We're excited to team up with a leader in healthcare such as Pfizer Consumer Healthcare to ...
 Sys-Con Media10 hours ago Jobs at Pfizer Nigeria  Latest Nigerian News.com1 week ago JPMorgan Chase : Global Health Investment Fund Provides Capital to Atomo Diagnostics  4 Traders3 hours ago Ministry of Health successfully concludes Pain and CNS Academy Conference  GoDubai.com13 hours ago
Sys-Con Italia

New York Former Pharma Executive shares candid reflections in memoir, Inflection Point

NEW YORK, Feb. 11, 2016 /PRNewswire/ -- Inflection Point is the true story of author and her legal team at Pfizer who found themselves at the epicenter of the decade long, multi-billion-dollar battle for control over the world's most prescribed ...
 TickerTech.com11 hours ago New York Former Pharma Executive Pens Memoir, INFLECTION POINT  Broadway World7 hours ago

April 1st Options Now Available For Pfizer (PFE)

Investors in Pfizer Inc (PFE) saw new options begin trading today, for the April 1st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PFE options chain for the new April 1st contracts and identified one put and ...
 Pettinga Financial Advisors8 hours ago
Good News From Finland

Pfizer inks research alliance with Breast Cancer Now

Pfizer has signed up to an initiative established by Breast Cancer Now, giving researchers access to marketed and investigational drugs in its oncology portfolio that can be used to deliver new therapies more quickly. The charity has unveiled its ...
 Pharma Field1 day ago Industry, researchers and funders to accelerate development of breast cancer treatments  Manufacturing Chemist1 day ago PFIZER : Breast Cancer Now Catalyst Programme aims to stop breast cancer  4 Traders2 days ago Finnish researchers and Pfizer develop targeted cancer drugs  Good News From Finland3 days ago

Why Pfizer (PFE) Stock Is Rising Today

NEW YORK (TheStreet) -- Pfizer (PFE - Get Report) stock is advancing 2.39% to $29.80 in afternoon trading on Wednesday after an advisory panel to the FDA recommended approval of a cheaper version of Johnson & Johnson's (JNJ) arthritis drug Remicade.
 TheStreet.com1 day ago Pfizer (PFE) Stock Rises, BofA/Merrill Lynch Names Top Pick  TheStreet.com2 days ago

Pfizer's Biosimilar of Remicade Recommended for Approval

Pfizer Inc. PFE announced that the FDA's Arthritis Advisory Committee has recommended an approval (by a vote of 21 to 3) of its experimental biosimilar of Johnson & Johnson's JNJ Remicade (infliximab). The committee recommended the approval of the ...
 Yahoo! Finance1 day ago Eliquis receives EU approval  Hospital Pharmacy Europe1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - pfizer
Get updated on latest news & your favorite topics right in your inbox!
More     Less